First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx
First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx
First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Demographic and baseline characteristics (2)<br />
Parameter n Mean (SD) Min-max<br />
Age (years) 5 46 (12) 31-60<br />
Weight (kg) 5 85 (30) 52-118<br />
BMI (kg/m²) 5 31,3 (9,7) 20-45<br />
Platelet count (10 9 /L) 5 27 (15) 7-41<br />
LDH (U/L) 5 1646 (880) 909-2795<br />
RICO (%) 5 95 (35) 41-120<br />
vWF:Ag (%) 5 233 (126) 114-420<br />
Nanobodies ® FV<strong>II</strong>I:C (%) 5 197 (89) 76-315 -<br />
ADAMTS13 (CBA) (%) 4 39 (38) Inspired by
Change language